EMEA-001492-PIP01-13-M01

Key facts

Active substance
Trifarotene
Therapeutic area
Dermatology
Decision number
P/0099/2017
PIP number
EMEA-001492-PIP01-13-M01
Pharmaceutical form(s)
Cream
Condition(s) / indication(s)
Treatment of acne
Route(s) of administration
Cutaneous use
Contact for public enquiries
Galderma International S.A.S

E-mail: Morgan.DANVEL@galderma.com
Tel.: +41 21924 9886

Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-001492-PIP01-13-M01
Compliance opinion date
29/06/2018
Compliance outcome
positive

Decision

How useful was this page?

Add your rating